Plain-English translation of NCT05621746 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that follows people with hemophilia A who have recently switched to a medication called to prevent bleeding episodes. The study will track how your joint health changes over time while you're taking this treatment, by asking you questions every six months about your joints, pain levels, and ability to stay active.
Hemophilia can cause bleeding into the joints, which damages them over time and limits mobility. Researchers want to understand whether this medication helps preserve joint health better than previous treatments, so they can give patients and doctors better information about long-term outcomes.
You likely qualify if…
You likely don't qualify if…
You will continue taking exactly as your doctor prescribed — the study doesn't change your treatment. Every six months for up to two years, you'll complete brief questionnaires about your joint pain, joint health, and how physically active you are. Your participation is completely voluntary, and you can leave the study at any time without affecting your medical care.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Canada